Ticker

IRD

Opus Genetics, Inc.

15 catalysts on file

IRD

Opus Genetics, Inc.

Phase 1 AI-extracted

OPGx-LCA5

Leber Congenital Amaurosis (LCA5)

156d ago ~ May 31, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 2 AI-extracted

OPGx-BEST1

BEST1-Related IRD

126d ago Jun 30, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 3 AI-extracted

Phentolamine Ophthalmic Solution 0.75%

mesopic, low-contrast conditions after keratorefractive surgery

126d ago ~ Jun 30, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 2 AI-extracted

Phentolamine Ophthalmic Solution 0.75%

presbyopia

126d ago Jun 30, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

PDUFA AI-extracted

Phentolamine

presbyopia

63d ago Sep 1, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

PDUFA Confirmed

Phentolamine Ophthalmic Solution 0.75%

presbyopia

17d ago Oct 17, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 1 AI-extracted

RDH12

inherited retinal disease

T-minus 58 days ~ Dec 31, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 1 AI-extracted

LCA5

inherited retinal disease

T-minus 58 days ~ Dec 31, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 3 AI-extracted

OPGx-LCA5

Leber Congenital Amaurosis (LCA) due to biallelic mutations in the LCA5 gene

T-minus 58 days ~ Dec 31, 2026

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 1 AI-extracted

RHO

inherited retinal disease

T-minus 423 days ~ Dec 31, 2027

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 1 AI-extracted

MERTK

inherited retinal disease

T-minus 423 days ~ Dec 31, 2027

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Phase 3 AI-extracted

LCA5

inherited retinal disease

T-minus 423 days ~ Dec 31, 2027

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Catalyst AI-extracted

OPGx-LCA5

T-minus 514 days ~ Mar 31, 2028

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Approval AI-extracted

OPGx-LCA5

T-minus 514 days ~ Mar 31, 2028

SEC 8-K verified 4mo ago

Countdown card →

IRD

Opus Genetics, Inc.

Approval AI-extracted

Phentolamine Ophthalmic Solution 0.75%

presbyopia

Date TBD Date TBD

SEC 8-K verified 4mo ago

Countdown card →